The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Grossi Federico since 2018.
This trader's CIK number is 1720634.
At the time of last reporting, Grossi Federico was the Chief Medical Officer of Apellis Pharmaceuticals, Inc.. (stock ticker symbol APLS).
Also see all insider trading activities at Apellis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | APLS | 0 | $0 | 2,500 | $121,975 | 0 | $0 |
| 2022 | APLS | 0 | $0 | 12,250 | $616,415 | 23,261 | $98,832 |
| 2021 | APLS | 0 | $0 | 18,500 | $881,882 | 40,000 | $143,400 |
| 2020 | APLS | 0 | $0 | 4,106 | $124,926 | 13,000 | $41,600 |
| 2018 | APLS | 0 | $0 | 0 | $0 | 14,750 | $47,200 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-05 | APLS | Sale | 2,500 | 48.79 | 121,975 |
| 2022-10-03 | APLS | Sale | 2,500 | 66.69 | 166,725 |
| 2022-08-01 | APLS | Sale | 2,500 | 55.99 | 139,975 |
| 2022-06-01 | APLS | Sale | 2,500 | 41.78 | 104,450 |
| 2022-05-02 | APLS | Sale | 2,500 | 43.56 | 108,900 |
| 2022-03-15 | APLS | Option Ex | 7,000 | 4.31 | 30,169 |
| 2022-03-15 | APLS | Sale | 375 | 39.57 | 14,838 |
| 2022-03-01 | APLS | Sale | 375 | 43.53 | 16,323 |
| 2022-02-23 | APLS | Option Ex | 4,100 | 4.31 | 17,671 |
| 2022-02-15 | APLS | Sale | 375 | 45.43 | 17,036 |
| 2022-02-14 | APLS | Option Ex | 3,600 | 4.31 | 15,515 |
| 2022-02-01 | APLS | Sale | 375 | 40.58 | 15,217 |
| 2022-01-14 | APLS | Sale | 375 | 40.56 | 15,210 |
| 2022-01-14 | APLS | Option Ex | 3,400 | 4.31 | 14,653 |
| 2022-01-12 | APLS | Option Ex | 5,161 | 4.04 | 20,824 |
| 2022-01-03 | APLS | Sale | 375 | 47.31 | 17,741 |
| 2021-12-15 | APLS | Sale | 375 | 42.88 | 16,080 |
| 2021-12-08 | APLS | Option Ex | 7,000 | 3.76 | 26,320 |
| 2021-12-01 | APLS | Sale | 375 | 42.40 | 15,900 |
| 2021-11-15 | APLS | Sale | 625 | 43.50 | 27,187 |
| 2021-11-01 | APLS | Sale | 625 | 30.70 | 19,187 |
| 2021-10-14 | APLS | Sale | 750 | 34.57 | 25,927 |
| 2021-10-01 | APLS | Sale | 750 | 33.26 | 24,945 |
| 2021-09-28 | APLS | Option Ex | 4,000 | 3.76 | 15,040 |
| 2021-08-02 | APLS | Sale | 250 | 63.99 | 15,997 |
| 2021-07-14 | APLS | Sale | 500 | 64.68 | 32,340 |
| 2021-07-08 | APLS | Sale | 250 | 65.68 | 16,420 |
| 2021-06-28 | APLS | Option Ex | 9,000 | 3.76 | 33,840 |
| 2021-05-14 | APLS | Sale | 500 | 45.39 | 22,695 |
| 2021-05-03 | APLS | Sale | 600 | 50.73 | 30,437 |
| 2021-04-14 | APLS | Sale | 500 | 42.82 | 21,410 |
| 2021-04-01 | APLS | Sale | 600 | 43.41 | 26,045 |
| 2021-03-15 | APLS | Sale | 500 | 46.77 | 23,385 |
| 2021-03-05 | APLS | Option Ex | 5,000 | 3.20 | 16,000 |
| 2021-03-05 | APLS | Sale | 5,000 | 48.62 | 243,075 |
| 2021-03-01 | APLS | Sale | 600 | 48.58 | 29,148 |
| 2021-02-16 | APLS | Sale | 500 | 46.00 | 23,000 |
| 2021-02-01 | APLS | Sale | 600 | 44.00 | 26,400 |
| 2021-01-25 | APLS | Option Ex | 15,000 | 3.48 | 52,200 |
| 2021-01-14 | APLS | Sale | 4,000 | 51.99 | 207,960 |
| 2021-01-04 | APLS | Sale | 600 | 57.24 | 34,344 |
| 2020-12-04 | APLS | Option Ex | 7,250 | 3.20 | 23,200 |
| 2020-11-16 | APLS | Option Ex | 5,750 | 3.20 | 18,400 |
| 2020-11-02 | APLS | Sale | 600 | 31.09 | 18,654 |
| 2020-10-01 | APLS | Sale | 600 | 30.22 | 18,132 |
| 2020-09-01 | APLS | Sale | 600 | 31.58 | 18,948 |
| 2020-08-03 | APLS | Sale | 600 | 26.28 | 15,768 |
| 2020-07-01 | APLS | Sale | 850 | 32.43 | 27,565 |
| 2020-06-15 | APLS | Sale | 856 | 30.21 | 25,859 |
| 2018-11-14 | APLS | Option Ex | 6,250 | 3.20 | 20,000 |
| 2018-04-11 | APLS | Option Ex | 8,500 | 3.20 | 27,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grossi Federico (Chief Medical Officer of Apellis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.